Jove
Visualize
Contact Us

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Agent-Based Modeling of Idiopathic Lung Fibrosis and Mechanistic Treatments.

bioRxiv : the preprint server for biology·2026
Same author

Murine Biocompatibility Evaluation of an Albumin-Derived Complex and Nanoparticle Delivery System for Ocular Applications.

Journal of biomedical materials research. Part A·2026
Same author

Spectrophotometric determination of LAP photoinitiator radicalization in ophthalmic applications.

Biomedical materials (Bristol, England)·2026
Same author

Modeling and Design of Multi-layered Cylindrical Microcapsules for Intravitreal Controlled Release.

bioRxiv : the preprint server for biology·2026
Same author

Mathematical Modeling of Bone Remodeling after Surgical Menopause.

bioRxiv : the preprint server for biology·2025
Same author

Multi-cellular network model predicts alterations in glomerular endothelial structure in diabetic kidney disease.

PLoS computational biology·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 29, 2025

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

32.3K

Computer Modeling of Bevacizumab Drug Distribution After Intravitreal Injection in Rabbit and Human Eyes.

Jabia M Chowdhury, Eduardo A Chacin Ruiz, Matthew P Ohr

    Biorxiv : the Preprint Server for Biology
    |May 22, 2023
    PubMed
    Summary

    This study models bevacizumab (anti-VEGF drug) pharmacokinetics in the eye. It reveals anterior elimination is key in rabbits, while both anterior and posterior routes matter in humans for wet AMD treatment.

    More Related Videos

    Author Spotlight: Optimizing Retinal Tissue Processing for Immunohistochemistry in Rabbit Models
    05:59

    Author Spotlight: Optimizing Retinal Tissue Processing for Immunohistochemistry in Rabbit Models

    Published on: November 10, 2023

    1.8K
    Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy
    11:03

    Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy

    Published on: January 22, 2018

    10.1K

    Related Experiment Videos

    Last Updated: Jul 29, 2025

    Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
    10:02

    Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

    Published on: July 23, 2016

    32.3K
    Author Spotlight: Optimizing Retinal Tissue Processing for Immunohistochemistry in Rabbit Models
    05:59

    Author Spotlight: Optimizing Retinal Tissue Processing for Immunohistochemistry in Rabbit Models

    Published on: November 10, 2023

    1.8K
    Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy
    11:03

    Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy

    Published on: January 22, 2018

    10.1K

    Area of Science:

    • Ophthalmology
    • Pharmacokinetics
    • Biomedical Engineering

    Background:

    • Age-related macular degeneration (AMD) is a leading cause of vision loss with no cure.
    • Wet AMD, the neovascular form, is managed using anti-VEGF therapies like bevacizumab.
    • Understanding bevacizumab's pharmacokinetic behavior in the vitreous is crucial for optimizing wet AMD treatment.

    Purpose of the Study:

    • To develop and validate spatial pharmacokinetic models for bevacizumab in rabbit and human vitreous.
    • To investigate the impact of different elimination routes on drug clearance.
    • To assess how injection location influences drug concentration and duration of action in the vitreous.

    Main Methods:

    • Development of two spatial pharmacokinetic models representing rabbit and human vitreous humor.
    • Simulation of various drug elimination scenarios and injection sites.
    • Validation of model predictions against experimental data.

    Main Results:

    • Anterior elimination significantly impacts bevacizumab clearance in rabbit vitreous.
    • Both anterior and posterior elimination routes are important for bevacizumab clearance in human vitreous.
    • Posterior injections of bevacizumab prolong effective drug concentrations in the vitreous.

    Conclusions:

    • The developed models provide insights into bevacizumab pharmacokinetics in ocular tissues.
    • Findings suggest optimizing injection strategies can enhance bevacizumab efficacy for wet AMD.
    • This research aids in understanding and improving therapeutic outcomes for patients with wet AMD.